Abstract: A control device includes: a retry determination unit configured to determine whether to execute retry control based on a current position of a moving object and a target position when the moving object is moved to the target position by automatic steering; and a notification control unit configured to transmit a retry notification, including information indicating that the retry control is to be executed based on a determination result of the retry determination unit, to a terminal device. The notification control unit transmits the retry notification to the terminal device when the retry control, executed after at least a part of the moving object reaches the target position, is determined, and the notification control unit does not transmit the retry notification to the terminal device when the retry control, executed before at least a part of the moving object reaches the target position, is determined.

Abstract: A stop assist system for moving a moving body to a stop position and making the moving body stop at the stop position includes: an external environment recognizing unit that recognizes an external environment of the moving body; and a moving body control unit that executes a driving process to make the moving body travel to the stop position based on a recognition result of the external environment recognizing unit. The moving body control unit suspends the driving process when, while the moving body is traveling to the stop position, the moving body control unit determines, based on the recognition result, that there is an object within a range of a prescribed lateral threshold value on a lateral outside of the moving body and the object extends over a prescribed longitudinal threshold value or more along a travel direction within the range.

Abstract: Disclosed herein is a data transfer circuit including, a plurality of data transfer lines, a plurality of data outputting sections, a plurality of data holding sections, a data-acquiring-clock supplying section a clock supplying section, and a column scan section.

Abstract: Disclosed herein is a data transfer circuit including, a plurality of data transfer lines, a plurality of data outputting sections, a plurality of data holding sections, a data-acquiring-clock supplying section a clock supplying section, and a column scan section.

Abstract: A process for producing 2-keto-L-gulonic acid which comprises converting L-sorbose and/or D-sorbitol into 2-keto-L-gulonic acid with the aid of a microorganism or its cell free extract, said microorganism belonging to the species Gluconobacter oxydans capable of producing 2-keto-L-gulonic acid and having L-sorbose dehydrogenase activity. Also disclosed are specific microorganisms useful in such process.

Abstract: A novel coenzyme independent L-sorbosone dehydrogenase originating from a microorganism belonging to the genus Gluconobacter oxydans which acts on L-sorbosone to produce 2-keto-L-gulonic acid.The enzyme has the following physico-chemical properties:a) optimum pH: about 7.0,b) optimum temperature: about 30.degree. C. to about 40.degree. C.,c) molecular sturucture: consisting of one type of unit having a molecular weight of about 47,500.+-.5,000 as measured by sodium dodecyl sulfate polyacrylamide gel electrophoresis,d) thermostability: stable below 30.degree. C., ande) inhibition: by Cu.sup.2+ -ions.

Abstract: A coenzyme-independent L-sorbosone dehydrogenase has been prepared from a microorganism belong to the genus Pseudomonas, which acts on L-sorbosone to produce 2-keto-L-gulonic acid. The enzyme is membrane bound and has a molecular weight of about 47,000 kDa. The enzyme is used to carry out the conversion of L-sorbosone to 2-keto-L-gulonic acid.

Abstract: The present invention relates to novel coenyme independent L-sorbose dehydrogenase and a process for producing the same. The enzyme provided by the present invention catalyzes the oxidation of L-sorbose to L-sorbosone, the precursor of 2-keto-L-gulonic acid which is an important intermediate in the production of vitamin C.Due to the release duties in foreign countries, the original deposits with respect to the following strains have been transferred to the deposit under the Budapest Treaty at Agency of Industrial Science and Technology, Fermentation Research Institute, Japan on Jan. 29, 1987. And the following accession numbers have been allotted to each strain.______________________________________ strain Old No. New No. ______________________________________ Gluconobacter oxydans FERM-P No. 8422, Accession No. UV-10 FERM BP-1267 Gluconobacter oxydans E-1 FERM-P No. 8353, Accession No. FERM BP-1265 Gluconobacter oxydans H-2 FERM-P No. 8354, Accession No. FERM BP-1266 Gluconobacter oxydans L-8 FERM-P No.

Abstract: The present invention relates to novel enzyme having L-sorbosone dehydrogenase activity and a process for producing the same. This L-Sorbosone dehydrogenase enzyme provided by the present invention catalyzes the oxidation of L-sorbosone to 2-keto-L-gulonic acid in the presence of nicotinamide adenine dinucleotide or nicotinamide adenine dinucleotide phosphate as a coenzyme. 2-KGA is an important precursor for the production of vitamin C.

Abstract: There is presented the compounds 4-deoxy-aclacinomycin A and B and pharmaceutical preparations containing the same. The preparations are effective against bacteria and tumours. Also presented is a process for the preparation of optically active anthracycline glycosides A and B with the 7S-configuration starting from racemic anthracyclinones.

Abstract: There is presented the compounds 4-deoxy-aclacinomycin A and B and pharmaceutical preparations containing the same. The preparations are effective against bacteria and tumours. Also presented is a process for the preparation of optically active anthracycline glycosides A and B with the 7S-configuration starting from racemic anthracyclinones.

Abstract: The present invention is concerned with novel anthracyclines which are compounds of the general formula, ##STR1## wherein R.sub.1 is a methyl or acetonyl group and R.sub.2 is selected from the group consisting of ##STR2## Also presented is a method of making the above compounds. The compounds possess antibacterial and antitumor activities.

Abstract: There is presented a process for producing anthracycline glycosides A by converting the sugar moiety of anthracycline glycosides B, represented by the following formula: ##STR1## into the sugar moiety of anthracycline glycosides A, represented by the following formula: ##STR2## with the aid of a microorganism belonging to the species Streptomyces galilaeus or Streptomyces melanogenes.

Abstract: The invention relates to a process for producing 1.alpha.-hydroxydehydroepiandrosterone by fermenting or reacting dehydroepiandrosterone or a derivative thereof with microorganisms of the species Penicillium oxalicum or Aspergillus terreus or mycelium or extracts therefrom obtained when the microorganisms are in a stationary phase of growth. The invention process produces steroid compounds which are pharmacologically valuable substances.

Abstract: The present invention relates to a process for producing aclacinomycins A and B. More particularly, the present invention is concerned with a process for producing selectively aclacinomycins A and B in high yield without formation of cinerubins A and B, by means of a fermentation process, utilizing Streptomyces galilaeus OBB-731.

Abstract: The invention relates to a process for producing 7.sub..alpha. -hydroxylated steroids by fermenting or reacting a steroid to be hydroxylated with microorganisms of the genus Botryodiplodia or enzyme extracts thereof until hydroxylation occurs. The invention process produces steroid compounds which are pharmacologically valuable substances.

Abstract: There is disclosed compounds of the formula ##STR1## wherein R.sup.1 represents a methyl or acetonyl group and R.sup.2 represents a hydrogen atom, a hydroxyl group or a group of the formula ##STR2## and a process for the preparation thereof. The compounds are useful as intermediates for the preparation of anthracycline antibiotics and certain of the compounds exhibit per se activity as antibacterial and antitumor agents.

Abstract: A novel antibiotic having the ascribed formula ##STR1## is provided. They physical characteristics are as follows: (a) Elementary analysis: Calculated (for C.sub.20 H.sub.16 O.sub.7): C,65.22; H,4.35%. Found: C,64.60; H,4.34%.(b) Molecular weight (mass-spectrometric): 368.(c) Melting point: 225.degree.-226.degree. C.(d) Specific rotation: [.alpha.].sub.D .sup.20 =+123.5.degree. (c=0.2 in chloroform).(e) Ultraviolet absorption spectrum:.lambda..sub.max .sup.methanol =235 nm (.epsilon.=28600); 262 nm (.epsilon.=21900); 434-435 nm (.epsilon.=11300);.lambda..sub.max .sup.0.1-N NaOH/methanol =246 nm (.epsilon.=22400); 256 nm (.epsilon.=23200); 523-524 nm (.epsilon.=9600).(f) Infrared absorption spectrum: 3500, 1710, 1672, 1628, 1600, 1575, 1472, 1452, 1420, 1390, 1295, 1255, 1218, 1200, 1182, 1105, 1025, 1005, 962, 938, 848, 765, 752, 730 cm.sup.-1.

Abstract: The preparation of D-arabitol by a fermentative process utilizing a micro-organism of the species Pichia haplophila or mutants thereof in a nutrient medium containing as a carbon source a hydrocarbon or ethyl alcohol is disclosed.

Abstract: A fermentation process for the preparation of 7.alpha.-hydroxylated steroids utilizing strains of the genus Mucor is disclosed. The 7.alpha.-hydroxylated steroids are useful intermediates for the synthesis of chenodeoxycholic acid as well as steroidal hormones.